These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34680938)

  • 41. SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance.
    Fazio M; van Rooijen E; Dang M; van de Hoek G; Ablain J; Mito JK; Yang S; Thomas A; Michael J; Fabo T; Modhurima R; Pessina P; Kaufman CK; Zhou Y; White RM; Zon LI
    Elife; 2021 Feb; 10():. PubMed ID: 33527896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SWItching on the transcriptional circuitry in melanoma.
    Vinod Saladi S; Marathe H; de la Serna IL
    Epigenetics; 2010 Aug; 5(6):469-75. PubMed ID: 20543574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockdown of aristaless-like homeobox1 inhibits epithelial-mesenchymal transition through Wnt/β-catenin signaling pathway in melanoma cells.
    Jiao JX; Jiao LJ; Yang S; Zhao YJ
    Biochem Biophys Res Commun; 2019 Mar; 511(1):105-110. PubMed ID: 30773258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of distinct molecular profile of Primary Dermal Melanoma.
    Shaigany S; Tessier-Cloutier B; Busam KJ; Horst BA
    Hum Pathol; 2020 Dec; 106():32-38. PubMed ID: 32946880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A gene expression signature of invasive potential in metastatic melanoma cells.
    Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR
    PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTEN Methylation Dependent Sinonasal Mucosal Melanoma.
    Lee SH; Roh MR; Kang B; Park KH; Kim SH; Lee SE; Rha SY
    Cancer Res Treat; 2016 Apr; 48(2):853-8. PubMed ID: 25797573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
    Deng W; Fernandez A; McLaughlin SL; Klinke DJ
    J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype.
    Vandamme N; Denecker G; Bruneel K; Blancke G; Akay Ö; Taminau J; De Coninck J; De Smedt E; Skrypek N; Van Loocke W; Wouters J; Nittner D; Köhler C; Darling DS; Cheng PF; Raaijmakers MIG; Levesque MP; Mallya UG; Rafferty M; Balint B; Gallagher WM; Brochez L; Huylebroeck D; Haigh JJ; Andries V; Rambow F; Van Vlierberghe P; Goossens S; van den Oord JJ; Marine JC; Berx G
    Cancer Res; 2020 Jul; 80(14):2983-2995. PubMed ID: 32503808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional regulators and alterations that drive melanoma initiation and progression.
    Gupta R; Janostiak R; Wajapeyee N
    Oncogene; 2020 Nov; 39(48):7093-7105. PubMed ID: 33024276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
    Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
    Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
    Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
    Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
    Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
    [No Abstract]   [Full Text] [Related]  

  • 55. Nuclear factor one transcription factors as epigenetic regulators in cancer.
    Fane M; Harris L; Smith AG; Piper M
    Int J Cancer; 2017 Jun; 140(12):2634-2641. PubMed ID: 28076901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
    Wessely A; Steeb T; Berking C; Heppt MV
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. α-Catulin downregulates E-cadherin and promotes melanoma progression and invasion.
    Kreiseder B; Orel L; Bujnow C; Buschek S; Pflueger M; Schuett W; Hundsberger H; de Martin R; Wiesner C
    Int J Cancer; 2013 Feb; 132(3):521-30. PubMed ID: 22733455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying and targeting determinants of melanoma cellular invasion.
    Jayachandran A; Prithviraj P; Lo PH; Walkiewicz M; Anaka M; Woods BL; Tan B; Behren A; Cebon J; McKeown SJ
    Oncotarget; 2016 Jul; 7(27):41186-41202. PubMed ID: 27172792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elucidation of the Genomic-Epigenomic Interaction Landscape of Aggressive Prostate Cancer.
    Kumar Mamidi TK; Wu J; Hicks C
    Biomed Res Int; 2021; 2021():6641429. PubMed ID: 33511206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.